Plunkett Research Online: Immune Design Corp

IMMUNE DESIGN CORP (IMDZ:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Immune Design is a clinical-stage immunotherapy company. Its focus is next-generation in vivo methods intended to enable the body’s immune system to fight diseases. The company’s therapies have a broad potential approach across multiple therapeutic areas. Nevertheless, the company’s target is oncolo.....



Immune Design Corp
Ticker: IMDZ
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 682-0645
Fax: 206 682-0648
Address: 1616 Eastlake Avenue East
Suite 310
Seattle, WA 98102 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Stephen BradyCFO/Chief Accounting Officer/Executive VP, Divisional
Sergey YurasovChief Medical Officer/Senior VP, Divisional
See More
Immune Design is a clinical-stage immunotherapy company. Its focus is next-generation in vivo methods intended to enable the body’s immune system to fight diseases. The company’s therapies have a broad potential approach across multiple therapeutic areas. Nevertheless, the company’s target is oncolo.....See More See More

Auditor: ERNST & YOUNG, LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: